Literature DB >> 18030179

Polymyxin B-immobilized fiber hemoperfusion with the PMX-05R column in elderly patients suffering from septic shock.

Tsukasa Nakamura1, Yasuhiro Kawagoe, Tsukasa Suzuki, Hisataka Shoji, Yoshihiko Ueda, Hikaru Koide.   

Abstract

BACKGROUND: Direct hemoperfusion with the polymyxin B-immobilized fiber (PMX-20R) column has a positive effect on outcome in patients with sepsis or septic shock. The PMX-05R column has a low priming volume and has been used in pediatric patients with septic shock. The aim of the present study was to determine whether PMX-F treatment with the PMX-05R column is effective in elderly patients with septic shock. PATIENTS AND METHODS: We performed direct hemoperfusion twice with the PMX-05R column in 8 septic shock patients who were over 80 years of age. Five of the 8 patients survived. The 3 patients who died were undergoing hemodialysis for chronic renal failure, and methicillin-resistant Staphylococcus aureus was detected in all 3.
RESULTS: PMX-F treatment significantly increased systolic and diastolic blood pressures (P = 0.0004 for both) and significantly reduced heart rate (P < 0.0001), the blood endotoxin level (P = 0.0011), blood IL-6 level (P = 0.039), C-reactive protein level (P < 0.0001), and white blood cell count (P < 0.0001).
CONCLUSIONS: Direct hemoperfusion with the PMX-05R column is effective in ameliorating clinical and laboratory abnormalities in elderly septic shock patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18030179     DOI: 10.1097/MAJ.0b013e3180a5e8d8

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  5 in total

1.  Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial.

Authors:  Didier M Payen; Joelle Guilhot; Yoann Launey; Anne Claire Lukaszewicz; Mahmoud Kaaki; Benoit Veber; Julien Pottecher; Olivier Joannes-Boyau; Laurent Martin-Lefevre; Matthieu Jabaudon; Olivier Mimoz; Rémi Coudroy; Martine Ferrandière; Eric Kipnis; Carlos Vela; Stéphanie Chevallier; Jihad Mallat; René Robert
Journal:  Intensive Care Med       Date:  2015-04-11       Impact factor: 17.440

2.  The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: A randomized controlled trial.

Authors:  Dirk Schädler; Christine Pausch; Daniel Heise; Andreas Meier-Hellmann; Jörg Brederlau; Norbert Weiler; Gernot Marx; Christian Putensen; Claudia Spies; Achim Jörres; Michael Quintel; Christoph Engel; John A Kellum; Martin K Kuhlmann
Journal:  PLoS One       Date:  2017-10-30       Impact factor: 3.240

Review 3.  Anti-endotoxin Properties of Polymyxin B-immobilized Fibers.

Authors:  Tohru Tani; Tomoharu Shimizu; Masaji Tani; Hisataka Shoji; Yoshihiro Endo
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

4.  Polymyxin B and low-dose hydrocortisone treatment in a patient with uroseptic shock in a rural health unit.

Authors:  Toshio Arai; Yuichiro Mori; Saori Yoshizaki; Ryo Ando; Shunsuke Natori; Shun Morishita; Miyu Otani; Atsushi Numata; Hiroaki Osanai
Journal:  Oxf Med Case Reports       Date:  2021-11-25

Review 5.  History and current status of polymyxin B-immobilized fiber column for treatment of severe sepsis and septic shock.

Authors:  Tomoharu Shimizu; Toru Miyake; Masaji Tani
Journal:  Ann Gastroenterol Surg       Date:  2017-07-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.